Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

NCT01781975 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type I
Diabetes Mellitus, Insulin-Dependent, 1
Type 1 Diabetes Mellitus
Insulin-Dependent Diabetes Mellitus 1
IDDM

Interventions

DRUG: Imatinib Mesylate
DRUG: Placebo (For imatinib mesylate)

Sponsor

University of California, San Francisco

Collaborators

[object Object]